Hepatology

Liver Fibrosis

Expert Perspectives in Liver Fibrosis to Cover Key Topics in Liver Fibrosis Treatment

expert perspectives by Arun J. Sanyal, MD; Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD; Raymond T. Chung, MD

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Liver Fibrosis will feature selected topics in Liver Fibrosis that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts:

Raymond T. Chung, MD

Director of Hepatology and the Liver Center Vice Chief of Gastroenterology Massachusetts General Hospital Professor of Medicine Harvard Medical School Boston, MA

Arun J. Sanyal, MD

Interim Chair Division of Gastroenterology, Hepatology, and Nutrition Professor of Medicine, Physiology, and Molecular Pathology Virginia Commonwealth University School of Medicine Richmond, VA

Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD

Transplant Hepatologist and Chief of Clinical Research Affairs Avera Transplant Institute, Sioux Falls, SD Professor of Medicine and Director, Hepatology Course University of South Dakota Sanford School of Medicine Vermillion, SD

Community-Selected Topics:

Expert Roundtables

• Pharmacologic and Nonpharmacologic Interventions for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis • Personalized Medicine for Metabolic Fatty Liver Disease • Liver Fibrosis: Markers, Calculators, Tests, and Prognostic Tools • Risk Stratification in Fatty Liver Disease: Current Perspectives

Clinical Topic Updates

• Nonalcoholic Steatohepatitis: Monotherapies and Combination Therapies in Development • Halting the Progression of Liver Disease in Patients With Metabolic Syndrome • Imaging and Blood-Based Markers of Hepatic Fibrosis and Cirrhosis • Nonalcoholic Fatty Liver Disease: An Independent Risk Factor for Cardiovascular Disease Morbidity and Mortality?

Patient Care Perspectives

• Noninvasive Tests in the Monitoring and Management of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis • Detecting Liver Fibrosis in the Morbidly Obese Patient • Fibrosis and Cirrhosis: Multispecialty Care and Optimizing the Referral Pathway • Fatty Liver Disease: Partnerships Between Hepatology and Primary Care

Profile

Arun J. Sanyal, MD

Interim Chair
Division of Gastroenterology, Hepatology, and Nutrition
Professor of Medicine, Physiology, and Molecular Pathology
Virginia Commonwealth University School of Medicine
Richmond, VA

Profile

Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD

Transplant Hepatologist and Chief of Clinical Research Affairs
Avera Transplant Institute, Sioux Falls, SD
Professor of Medicine and Director, Hepatology Course
University of South Dakota Sanford School of Medicine
Vermillion, SD

Profile

Raymond T. Chung, MD

Director of Hepatology and the Liver Center
Vice Chief of Gastroenterology
Massachusetts General Hospital
Professor of Medicine
Harvard Medical School
Boston, MA

Hepatology

Liver Fibrosis

Expert Perspectives in Liver Fibrosis to Cover Key Topics in Liver Fibrosis Treatment

Overview

Raymond T. Chung, MD

Arun J. Sanyal, MD

Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD

Arun J. Sanyal, MD

Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD

Raymond T. Chung, MD

Explore More in Liver Fibrosis

Pharmacologic and Nonpharmacologic Interventions for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

Current Perspectives on Risk Stratification in Nonalcoholic Fatty Liver Disease

Personalized Medicine for Nonalcoholic Fatty Liver Disease

Liver Fibrosis: Markers, Calculators, Tests, and Prognostic Tools